GLP-1 Savings Programs: Every Discount Option Ranked [2026]
If you've been prescribed a GLP-1 medication for weight loss or diabetes and then seen the pharmacy price tag, you're not alone. The retail cost of Ozempic is $1,028/month. Wegovy is $1,349/month. Zepbound hits $1,088/month. Without savings programs, these medications are financially impossible for most Americans.
![GLP-1 Savings Programs: Every Discount Option Ranked [2026]](https://images.unsplash.com/photo-1584308666744-24d5c474f2ae?w=800&q=80)
Quick Answer: The cheapest GLP-1 option in 2026 is compounded semaglutide through telehealth providers at $99-$199/month. Manufacturer savings cards (Novo Nordisk, Eli Lilly) reduce commercially insured copays to $25/month. The TrumpRx program offers brand-name GLP-1s at $299-$399/month cash pay. Medicare will cap GLP-1 copays at $50/month starting July 2026 via a bridge program, and Medicaid provides zero cost-sharing. The new Wegovy pill (FDA-approved December 2025) starts at $149/month cash pay through 70,000+ pharmacies.
If you've been prescribed a GLP-1 medication for weight loss or diabetes and then seen the pharmacy price tag, you're not alone. The retail cost of Ozempic is $1,028/month. Wegovy is $1,349/month. Zepbound hits $1,088/month. Without savings programs, these medications are financially impossible for most Americans.
But 2026 has brought more discount options than ever before. The FDA-approved Wegovy pill launched in January 2026. Pharmacy chains like Kroger and Publix rolled out their own GLP-1 savings programs. Eli Lilly introduced multidose Zepbound KwikPens at lower prices. And the CMS BALANCE model is set to expand Medicare and Medicaid access later this year.
Between manufacturer savings cards, government programs, telehealth platforms, pharmacy discount programs, and compounding pharmacies, the actual price you pay can range from $0 to $500/month depending on your insurance status and which programs you qualify for.
This guide ranks every legitimate GLP-1 savings option available right now, from cheapest to most expensive, so you can find the lowest price for your specific situation.
Every GLP-1 Savings Program Ranked
Here's the complete landscape, ranked by effective monthly cost from lowest to highest:
| Rank | Program | Monthly Cost | Eligibility | Medications |
|---|---|---|---|---|
| 1 | Medicaid GLP-1 Coverage | $0 | Medicaid enrollees | Wegovy, Zepbound |
| 2 | Manufacturer Savings Cards | $25 | Commercial insurance with GLP-1 coverage | Ozempic, Wegovy, Mounjaro, Zepbound |
| 3 | Medicare Part D (July 2026) | $50 max | Medicare beneficiaries | Wegovy, Zepbound |
| 4 | Patient Assistance Programs | $0-$100 | Income-qualified, uninsured | Brand-name GLP-1s |
| 5 | Compounded Semaglutide | $99-$199 | Anyone with a prescription | Compounded semaglutide |
| 6 | Wegovy Pill (Cash Pay) | $149-$299 | Anyone with a prescription | Oral semaglutide (Wegovy tablet) |
| 7 | Compounded Tirzepatide | $149-$399 | Anyone with a prescription | Compounded tirzepatide |
| 8 | Pharmacy Discount Programs | $149-$199 | Cash-pay patients | Wegovy pill, Ozempic (select doses) |
| 9 | Zepbound Self-Pay (Multidose KwikPen) | $299-$449 | Cash-pay patients | Zepbound |
| 10 | TrumpRx Program | $299-$399 | U.S. residents with prescription | Ozempic, Wegovy, Zepbound |
| 11 | GoodRx Standard Pricing | $299-$499 | Cash-pay patients | Ozempic, Wegovy |
| 12 | Telehealth Bundles | $199-$499 | Anyone | Various (includes consultation) |
Let's break down each option in detail.
1. Medicaid GLP-1 Coverage (FREE)
Monthly cost: $0 cost-sharing
Under deals announced in late 2025 between the federal government and GLP-1 manufacturers, Medicaid enrollees now have zero cost-sharing for covered GLP-1 injectables. This is the single best deal available for GLP-1 medications.
The CMS BALANCE model will further expand Medicaid GLP-1 access starting as early as May 2026, with state Medicaid agencies voluntarily opting in to cover GLP-1 medications for weight management.
How to access:
- Must be enrolled in your state's Medicaid program
- GLP-1 must be prescribed for an approved indication (varies by state, but obesity coverage is expanding)
- Prior authorization may be required
- Contact your state Medicaid office or check your plan's formulary
Limitations:
- Not all states cover GLP-1s for weight loss (some only cover for type 2 diabetes)
- Prior authorization requirements can delay access by 2-4 weeks
- Formulary restrictions may limit which specific GLP-1 is covered
- Income limits for Medicaid eligibility vary by state
2. Manufacturer Savings Cards ($25/month)
Monthly cost: As low as $25 with commercial insurance
Both Novo Nordisk (maker of Ozempic and Wegovy) and Eli Lilly (maker of Mounjaro and Zepbound) offer savings cards that dramatically reduce out-of-pocket costs for commercially insured patients.
Novo Nordisk Savings Cards
| Medication | Savings Card Price | Max Monthly Savings | Duration | Activation |
|---|---|---|---|---|
| Ozempic | As low as $25 | $100/month | Up to 48 months | ozempic.com/savings |
| Wegovy (injectable) | As low as $25 | $100/month | Up to 48 months | wegovy.com/savings |
| Wegovy (pill) | As low as $25 | $100/month | Up to 48 months | wegovy.com/savings |
Eligibility requirements:
- Must have commercial (private) insurance that covers the medication
- NOT eligible: Medicare, Medicaid, Medigap, VA, DoD, TRICARE enrollees
- Must be a U.S. resident
- Savings card terms updated January 2, 2026
Eli Lilly Savings Cards
| Medication | Savings Card Price | Conditions | Activation |
|---|---|---|---|
| Mounjaro | As low as $25 | Commercially insured with coverage | mounjaro.com/savings |
| Zepbound | As low as $25 | Commercially insured with coverage | zepbound.lilly.com/savings |
How to activate:
- Visit the manufacturer website
- Complete the online enrollment form
- Receive your digital savings card
- Present the card at your pharmacy along with your insurance card
- Your copay is reduced to $25 or less
This is the best option for most commercially insured patients. If you have private insurance that covers your GLP-1 prescription, activate a savings card immediately.
How Real Patients Navigate Savings Cards
What real GLP-1 patients report about savings cards (from r/Ozempic / r/Mounjaro / r/Zepbound / r/Semaglutide, 2023–2025):
"$1100 is full retail price at Walmart. If you have a coupon / savings card, they should be taking at least $575 off that." — user on r/Mounjaro, 2023
"There's a manufacture coupon (Ozempic Savings Card) that takes UP to $150 off a month. It brings your total down to $25 IF it costs $175 after insurance. Ozempic for me is currently $281 - coupon = $131/pen." — user on r/Ozempic, 2024
"My guess is your insurance doesn't cover it at all. If it did, it could not be 'combined' with the savings coupon. If your insurance does NOT cover it, the savings coupon brings the cost to exactly $650." — user on r/Zepbound, 2025
"They do suck. I tried 3 pharmacies with the savings card, Walmart was the only one who filled the prescription and priced it at $1200 then tried the coupon and it blocked it saying I needed t2d diagnosis." — user on r/Semaglutide, 2023
For a complete breakdown of all GLP-1 medication costs, see our GLP-1 cost guide.
3. Medicare Part D GLP-1 Coverage ($50/month max)
Monthly cost: $50 maximum copay
This is a major development for 2026. Under the federal government's negotiated deals with Novo Nordisk and Eli Lilly, Medicare beneficiaries will have a $50/month maximum copay for GLP-1 injectables like Wegovy and Zepbound.
What's happening and when:
- A short-term Medicare GLP-1 bridge program launches in July 2026, giving Medicare Part D beneficiaries access to GLP-1s at the negotiated $245/month price (with a $50 max copay for patients)
- The full BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) model launches in Medicare Part D in January 2027
- Part D plan sponsors must apply to participate in BALANCE by April 20, 2026
- Coverage includes injectable GLP-1s for eligible individuals with severe obesity or related health conditions
How to access:
- Confirm your Part D plan's formulary includes the GLP-1 you need
- Your prescriber may need to submit prior authorization
- The $50 cap applies after your plan's deductible (if applicable)
- Contact Medicare at 1-800-MEDICARE for plan-specific details
For a deeper dive on Medicare coverage specifics, see our GLP-1 Medicare coverage guide.
4. Patient Assistance Programs ($0-$100/month)
Monthly cost: $0-$100 depending on income
For patients who are uninsured or underinsured and meet income requirements, both manufacturers offer patient assistance programs.
Novo Nordisk Patient Assistance Program (PAP)
- Provides free Ozempic for eligible patients
- Income-based eligibility (typically below 400% of Federal Poverty Level)
- Ozempic is being removed from PAP for Medicare Part D beneficiaries starting in 2026 (as Medicare coverage expands)
- Does NOT currently include Wegovy for weight loss
- Apply through NovoCare: 1-866-310-7549 or novocare.com
Eli Lilly Solutions Center
- Provides free or reduced-cost Mounjaro and Zepbound
- Income-based eligibility
- Apply through LillyTrialGuide.com or call 1-800-545-6962
Third-Party Assistance
| Organization | Coverage | Who Qualifies |
|---|---|---|
| HealthWell Foundation | Copay assistance | Patients with high copays |
| Patient Advocate Foundation | Co-pay relief | Patients with deductibles/copays |
| NeedyMeds | Database of programs | All patients (search tool) |
| RxAssist | Program directory | All patients (search tool) |
Important note: Patient assistance programs require documentation (tax returns, insurance denial letters) and approval can take 2-6 weeks. Start the application process early.
5. Compounded Semaglutide ($99-$199/month)
Monthly cost: $99-$199 through telehealth providers
Compounded semaglutide remains one of the most affordable GLP-1 options for cash-pay patients in 2026. These are custom-prepared versions of semaglutide made by licensed U.S. compounding pharmacies.
How it works:
- You get a prescription from a licensed provider (often through a telehealth consultation)
- The prescription is sent to a 503A or 503B compounding pharmacy
- The pharmacy prepares your semaglutide injection
- It's shipped directly to your home
Pricing by provider:
| Provider | Monthly Cost | Includes | Notes |
|---|---|---|---|
| Hims & Hers | $99-$199/month | Compounded semaglutide + provider visits | Oral compound starting at $49/mo (first month), $99/mo on 5-month plans |
| Ro | $145-$199/month | Compounded semaglutide + ongoing care | Starting dose at $145/month |
| CoreAge RX | $99/month | Compounded semaglutide | Competitive pricing |
| Found | $129-$199/month | Semaglutide + coaching | Included |
| Henry Meds | $149/month | Semaglutide + provider access | Included |
Regulatory update (March 2026): The FDA ended the official semaglutide shortage in February 2025, which means compounding is no longer permitted on the basis of a drug shortage. However, 503A pharmacies can still legally compound semaglutide with a patient-specific prescription from a licensed provider. The FDA has ramped up enforcement against unlicensed manufacturers, misleading marketing, and pharmacies using research-grade ingredients not intended for human use. Always verify your pharmacy is properly licensed with 503A or 503B designation.
For a detailed safety analysis, see our compounded semaglutide safety guide. For a comparison of the top telehealth providers, check our Hims vs Ro vs Found comparison.
6. Wegovy Pill — Cash Pay ($149-$299/month)
Monthly cost: $149-$299 depending on dose
The FDA approved the Wegovy pill on December 22, 2025, making it the first and only oral GLP-1 for weight loss in adults. It launched in the U.S. in January 2026 and is now broadly available through 70,000+ pharmacies including CVS, Costco, Kroger, and Publix.
Cash-pay pricing by dose:
| Dose | Monthly Cost | Notes |
|---|---|---|
| 1.5 mg (starting dose) | $149/month | Through April 15, 2026 |
| 4 mg | $149/month (through April 15), then $199/month | Price increase after intro period |
| 9 mg | $299/month | Standard pricing |
| 25 mg | $299/month | Standard pricing |
With insurance: The copay with commercial insurance and a savings card is about $25 or less, same as injectable Wegovy.
Where to get it: Available through CVS, Costco, Kroger, Publix, NovoCare Pharmacy, GoodRx, and telehealth providers including Ro, LifeMD, and Weight Watchers.
This is a game-changing option for patients who prefer pills over injections. For a detailed comparison, see our Wegovy pill vs injection guide.
7. Compounded Tirzepatide ($149-$399/month)
Monthly cost: $149-$399 depending on dose and provider
Compounded tirzepatide (the active ingredient in Mounjaro and Zepbound) is also available through compounding pharmacies, though regulatory pressure has increased.
Pricing range by dose:
| Dose | Typical Monthly Cost |
|---|---|
| 2.5mg (starting) | $149-$199 |
| 5mg | $199-$249 |
| 7.5mg | $249-$299 |
| 10mg | $299-$349 |
| 15mg | $349-$399 |
Regulatory note: The FDA ended compounding discretion for tirzepatide in March 2025, meaning compounding pharmacies face stricter requirements for tirzepatide than semaglutide. Some compounders have stopped offering tirzepatide while others operate under court orders. Availability is less reliable than compounded semaglutide.
Tirzepatide is a dual GIP/GLP-1 receptor agonist, which some patients find more effective than semaglutide alone. See our semaglutide vs tirzepatide comparison for help choosing between them.
8. Pharmacy Discount Programs ($149-$199/month)
Monthly cost: $149-$199 for select GLP-1 medications
Major pharmacy chains have launched their own GLP-1 savings programs in early 2026, making it easier to access discounted pricing in-store.
Publix Pharmacy
- Wegovy pills (1.5 mg and 4 mg): starting at $149/month
- Wegovy and Ozempic injectables (0.25 mg and 0.5 mg): starting at $199/month
- Available through a discount card program for a limited time
Kroger
- Participates in manufacturer savings programs to reduce costs
- Offers personalized GLP-1 counseling and education
- In select states, in-store or virtual evaluations with licensed providers who can prescribe GLP-1 medications
- Prescriptions from any provider can be filled at Kroger pharmacies
NovoCare Pharmacy
- Direct-from-manufacturer pharmacy service
- Introductory pricing matches manufacturer offers
- Home delivery available
These pharmacy programs are worth checking even if you've already been filling prescriptions elsewhere. The introductory pricing at Publix and Kroger can save cash-pay patients hundreds per month.
9. Zepbound Self-Pay — Multidose KwikPen ($299-$449/month)
Monthly cost: $299-$449 depending on dose
Eli Lilly introduced multidose Zepbound KwikPens in early 2026, offering a more affordable self-pay option than the original single-dose pens. Each KwikPen holds four doses (a one-month supply).
Self-pay pricing:
| Dose | Monthly Cost | Notes |
|---|---|---|
| 2.5 mg (starting) | $299/month | Multidose KwikPen |
| 5 mg | $299/month | Multidose KwikPen |
| 7.5 mg | $449/month | Available since February 23, 2026 |
| 10 mg | $449/month | Single-dose vial or KwikPen |
| 12.5 mg | $449/month | Single-dose vial or KwikPen |
| 15 mg | $449/month | Single-dose vial or KwikPen |
For patients with commercial insurance that doesn't cover Zepbound: The savings card brings the 2.5 mg dose to as low as $299/month (up to $215 in monthly savings). The savings card is valid through December 31, 2026.
These self-pay prices are available through LillyDirect and participating pharmacies.
10. TrumpRx Program ($299-$399/month)
Monthly cost: $299-$399 for brand-name GLP-1s
The TrumpRx program launched on February 6, 2026, at TrumpRx.gov. It emerged from negotiations between the federal government and GLP-1 manufacturers to offer most-favored-nation pricing on brand-name medications.
Pricing through TrumpRx:
| Medication | TrumpRx Price | vs. Retail Price | Savings |
|---|---|---|---|
| Ozempic | ~$399 avg (as low as $150 depending on dose) | $1,028/month | 61-85% off |
| Wegovy (injectable) | ~$399 avg (as low as $150 depending on dose) | $1,349/month | 70-89% off |
| Zepbound | ~$346 avg (as low as $299 depending on dose) | $1,088/month | 59-73% off |
| Oral GLP-1s (pending) | ~$150/month | TBD | TBD |
Price trajectory: The average price of GLP-1 injectables will start at ~$350/month on TrumpRx and trend down to $245/month over the next 24 months.
Eligibility:
- Must be a U.S. resident
- Must have a valid prescription from a licensed healthcare provider
- Available to both insured and uninsured patients
Important context: While TrumpRx pricing is significantly cheaper than retail, compounded semaglutide ($99-$199) and the Wegovy pill ($149-$299) are often cheaper. TrumpRx is most valuable if you specifically want brand-name injectable medication without insurance coverage.
11. GoodRx Standard Pricing ($299-$499/month)
Monthly cost: $299-$499 depending on medication and dose
GoodRx offers cash-pay pricing for brand-name GLP-1 medications:
| Medication | GoodRx Price | Retail Price | Savings |
|---|---|---|---|
| Ozempic 0.25mg/0.5mg | $349/month | $1,028/month | 66% |
| Ozempic 2mg | $499/month | $1,028/month | 51% |
| Wegovy (injectable) | $299-$349/month | $1,349/month | 74-78% |
| Wegovy pill (1.5mg/4mg) | $149/month (through April 15) | N/A | Intro pricing |
| Wegovy pill (9mg/25mg) | $299/month | N/A | Standard pricing |
GoodRx for Weight Loss subscription:
- Telemedicine subscription: $119/month (includes provider consultations)
- Combined with medication pricing for an all-in-one program
How to access:
- Visit goodrx.com or download the GoodRx app
- Search for your medication
- Compare prices at local pharmacies
- Present the GoodRx coupon at checkout
Important: GoodRx pricing is for cash-pay patients. If you have insurance that covers your GLP-1, the manufacturer savings card ($25/month) is almost certainly cheaper.
12. Telehealth Bundle Programs ($199-$499/month)
Monthly cost: $199-$499 all-inclusive
Several telehealth platforms bundle the medication, consultations, and ongoing monitoring into a single monthly fee:
| Provider | Monthly Cost | What's Included |
|---|---|---|
| Hims/Hers | $199-$299 | Medication + provider + shipping |
| Ro | $149-$299 | Medication + provider + coaching |
| Found | $129-$299 | Medication + provider + behavioral coaching |
| LifeMD | $199-$399 | Medication + provider + Wegovy pill access |
| Calibrate | $299-$499 | Medication + metabolic reset program |
| Noom GLP-1 | $149-$299 | Medication + Noom behavioral program |
The advantage of bundles is simplicity -- one price, one program, everything handled. The disadvantage is less flexibility in choosing your pharmacy or medication.
For a detailed comparison of telehealth programs, see our best online GLP-1 programs guide and our Hims vs Ro vs Found comparison.
Decision Flowchart: Which Program Is Right for You?
If you have commercial (private) insurance:
- Check if your plan covers your prescribed GLP-1
- If covered: Activate the manufacturer savings card ($25/month) -- this is your best option
- If not covered: Appeal the denial, then consider compounded semaglutide ($99-$199) or the Wegovy pill ($149) while you wait
If you have Medicare:
- The Medicare GLP-1 bridge program launches in July 2026 with a $50/month copay cap
- Check your Part D formulary for current GLP-1 coverage
- If not yet covered: Consider the TrumpRx program ($299-$399) or the Wegovy pill ($149-$299) until July
If you have Medicaid:
- Check your state's formulary -- you may qualify for $0 cost-sharing
- If your state covers GLP-1s for your indication: Enroll through your Medicaid plan
- The BALANCE model expands Medicaid GLP-1 coverage starting May 2026
- If not covered: Contact your state Medicaid office about expansion plans
If you're uninsured:
- First choice: Compounded semaglutide through telehealth ($99-$199/month)
- Second choice: Wegovy pill at introductory pricing ($149/month through April 15)
- Third choice: Zepbound multidose KwikPen ($299/month for starting dose)
- Fourth choice: TrumpRx program ($299-$399/month) for brand-name injectables
- Also check: Patient assistance programs for possible free medication
If you want brand-name but can't afford retail:
- Wegovy pill ($149-$299/month)
- Zepbound multidose KwikPen ($299-$449/month)
- TrumpRx ($299-$399/month)
- GoodRx standard ($299-$499/month)
Additional Ways to Save
Beyond the major programs above, here are supplementary strategies:
Ask About Samples
Prescribers often have manufacturer samples of Ozempic, Wegovy, Mounjaro, and Zepbound. A sample pen can cover 2-4 weeks of treatment, giving you time to get savings programs set up.
Dose Optimization
Some patients find that lower doses remain effective for weight maintenance after the initial weight loss phase. Discuss with your prescriber whether a lower dose (and thus lower cost) makes sense once you've reached your goal. See our best GLP-1 for weight loss vs diabetes guide.
The Wegovy Pill Advantage
The Wegovy pill (oral semaglutide) launched at $149/month for starting doses -- significantly cheaper than injectable Wegovy ($1,349 retail). If your prescriber agrees, switching from injectable to oral can save hundreds per month. For more on oral options, see our oral GLP-1 pills guide.
Flexible Spending / Health Savings Accounts
If you have an FSA or HSA, GLP-1 medications typically qualify as eligible expenses. This effectively gives you a tax discount (your marginal tax rate) on whatever you pay.
International Pharmacy Programs
Some patients use Canadian or international pharmacies for lower prices. Legality and safety vary -- we don't recommend this approach, but it exists. Verify any international pharmacy through the CIPA (Canadian International Pharmacy Association) database.
State-by-State Variation: Why Your Location Matters
GLP-1 access and savings vary significantly by state. Here's what makes a difference:
States with the Best GLP-1 Access (2026)
| State | Key Advantage | Details |
|---|---|---|
| California | Expanded Medi-Cal coverage | Covers GLP-1s for obesity, not just diabetes |
| New York | State supplement program | Additional savings on top of federal programs |
| Massachusetts | Broad MassHealth coverage | Among the first states to cover GLP-1s for weight management |
| Colorado | Competitive compounding pharmacy market | Multiple licensed pharmacies drive prices down |
| Texas | Large telehealth presence | Hims, Ro, Found all have strong TX infrastructure |
| Florida | Publix pharmacy discounts | Wegovy pill from $149/mo, injectables from $199/mo in-store |
States with the Most Limited Access
| State | Challenge | Workaround |
|---|---|---|
| Mississippi | Medicaid doesn't cover GLP-1 for obesity | Federal programs (TrumpRx), telehealth providers |
| Wyoming | Few in-state compounding pharmacies | Mail-order compounding from licensed out-of-state pharmacies |
| West Virginia | Limited Medicaid formulary | Manufacturer patient assistance programs |
| Idaho | Strict prior auth requirements | Work with prescriber on appeals documentation |
Insurance Variation by State
Even within the same insurance company, formulary coverage varies by state. United Healthcare may cover Wegovy in California but require step therapy in Georgia. Always check your specific plan's formulary -- don't rely on national-level information.
How to Check Your State's Coverage
- Medicaid: Visit your state Medicaid website and search the formulary, or call your state Medicaid helpline
- Commercial insurance: Log into your insurance portal, go to "Pharmacy" or "Formulary," and search for your specific medication
- Medicare Part D: Use Medicare's Plan Finder tool (medicare.gov/plan-compare) to check which plans in your area cover your medication
Timing Your Savings: When to Apply for What
The order in which you apply for programs matters. Here's the optimal sequence:
Step 1: Check Your Insurance (Week 1)
Before anything else, verify whether your current insurance covers GLP-1 medications. Log into your portal or call your insurance company. If covered, skip directly to manufacturer savings cards.
Step 2: Apply for Manufacturer Programs (Week 1-2)
Even before your prescription is filled, activate savings cards. They're instant -- you can often have a card within 24 hours. If you need patient assistance (income-based), apply simultaneously since those take longer.
Step 3: Get Your Prescription (Week 2-3)
See your doctor or start a telehealth consultation. Having your savings card ready before the prescription prevents sticker shock at the pharmacy.
Step 4: If Denied or Too Expensive, Pivot (Week 3-4)
If insurance denies coverage or your copay is still too high after savings cards:
- Appeal the denial (your doctor can help with medical necessity documentation)
- Try the Wegovy pill at $149/month (introductory pricing through April 15, 2026)
- Switch to compounded semaglutide ($99-$199/month)
- Check pharmacy discount programs at Publix or Kroger
- Apply for patient assistance programs (takes 2-6 weeks for approval)
Step 5: Watch for Medicare and Medicaid Expansion
If you have Medicare, mark July 2026 on your calendar. The Medicare GLP-1 bridge program launches then, capping your copay at $50/month. If you have Medicaid, the BALANCE model could expand your state's coverage as early as May 2026.
Step 6: Annual Review
GLP-1 pricing, formularies, and programs change regularly. Every January (open enrollment aftermath) and every July (mid-year formulary updates), re-check your options. A program that wasn't available when you started might save you hundreds.
For context on managing side effects during your first week after starting, see our Ozempic side effects first week guide. And to understand the full cost landscape beyond savings programs, check our GLP-1 medication cost guide.
Programs to Avoid
Not every "savings" offer is legitimate. Watch out for:
- Unlicensed compounding pharmacies: Always verify your pharmacy's state board license and look for 503A/503B designation. The FDA has been actively enforcing against unlicensed manufacturers and pharmacies using research-grade ingredients not intended for human use.
- Foreign peptide suppliers: Semaglutide sold as a "research peptide" from overseas vendors is unregulated and potentially unsafe
- Fake savings cards: Legitimate manufacturer cards come directly from ozempic.com, wegovy.com, mounjaro.com, or zepbound.lilly.com. Third-party "coupon" sites may collect your data
- Programs requiring large upfront payments: Legitimate savings programs don't require hundreds of dollars upfront before you receive medication
What's Coming Next
Several developments could further reduce GLP-1 costs in late 2026 and beyond:
- Orforglipron: An oral GLP-1 from Eli Lilly in late-stage development. If FDA-approved, it could cost ~$350/month through TrumpRx and potentially less through other channels. No injection needed. Medicare has already included it in the $50/month copay cap plan.
- BALANCE Model full launch: Medicare Part D GLP-1 coverage expands in January 2027 under the full BALANCE model. The bridge program starts July 2026.
- TrumpRx price reductions: The average GLP-1 price on TrumpRx is projected to trend down from ~$350 to $245/month over 24 months.
- Generic semaglutide: Not expected until Novo Nordisk's patent exclusivity expires, but pressure is mounting. See our generic semaglutide explainer.
- Expanded state programs: Several states are developing their own GLP-1 access programs, especially as BALANCE model participation grows
- Next-gen GLP-1s: Pipeline drugs may offer better efficacy at lower production costs. See our next-gen GLP-1 drugs guide.
FAQ
What is the cheapest way to get a GLP-1 medication in 2026? For commercially insured patients, the manufacturer savings card brings the copay to $25/month. For Medicaid enrollees, GLP-1s are now available at $0 cost-sharing in many states. For uninsured patients, compounded semaglutide through telehealth platforms costs $99-$199/month, and the new Wegovy pill starts at $149/month for cash-pay patients.
What is the Wegovy pill and how much does it cost? The Wegovy pill (oral semaglutide) was FDA-approved in December 2025 and launched in January 2026. It's the first oral GLP-1 for weight loss. Cash-pay pricing starts at $149/month for the 1.5 mg and 4 mg doses (through April 15, 2026), then $199/month for the 4 mg dose. Higher doses (9 mg, 25 mg) cost $299/month. With a manufacturer savings card and commercial insurance, the copay is about $25. It's available at 70,000+ U.S. pharmacies.
Does the TrumpRx program replace insurance for GLP-1 medications? No. TrumpRx is a cash-pay program that offers brand-name GLP-1s at $299-$399/month regardless of insurance status. If you have commercial insurance with GLP-1 coverage, the manufacturer savings card ($25/month) is substantially cheaper. TrumpRx is most valuable for patients who are uninsured or whose insurance doesn't cover GLP-1 medications and who want brand-name products.
When does Medicare start covering GLP-1s for weight loss? The Medicare GLP-1 bridge program launches in July 2026, capping beneficiary copays at $50/month. The full BALANCE model launches in Medicare Part D in January 2027. Medicare will pay $245/month per beneficiary for GLP-1 medications under these programs. Coverage includes injectable weight-loss medications for eligible individuals with severe obesity or related health conditions.
Can I use GoodRx AND a manufacturer savings card together? No. GoodRx coupons and manufacturer savings cards cannot be combined. They work through different discount pathways. If your insurance covers the medication, the manufacturer savings card is almost always the better deal at $25/month. GoodRx is better for cash-pay patients without insurance coverage.
Is compounded semaglutide still legal in 2026? Yes, but with more restrictions. The FDA ended the semaglutide shortage in February 2025, so shortage-based compounding is no longer permitted. However, 503A pharmacies can still legally compound semaglutide with a patient-specific prescription from a licensed provider. The FDA has increased enforcement against unlicensed manufacturers and pharmacies using substandard ingredients. Always verify your pharmacy's 503A or 503B license. See our full safety guide for details.
What happens to GLP-1 savings programs when I reach my weight loss goal? Most programs continue as long as you have an active prescription. However, some patients transition to lower maintenance doses, which may cost less. Discuss with your prescriber whether dose reduction is appropriate once you've reached your target weight. Some telehealth programs offer reduced pricing for maintenance-phase patients.
Prices verified as of March 30, 2026. GLP-1 medication costs change frequently due to manufacturer negotiations, insurance formulary updates, and government policy changes. Always verify current pricing through the specific program before making decisions. Key upcoming dates: Wegovy pill intro pricing changes April 15, 2026; Medicare GLP-1 bridge program launches July 2026.
This article is for informational purposes only and does not constitute medical or financial advice. Consult with your healthcare provider about which GLP-1 medication is right for you, and verify program eligibility before enrolling.
-- The GLP-1 Daily Team
On Google
Get our answers in your Google results.
Add The GLP-1 Daily as a preferred source and Google will surface our reporting more often — in Top Stories and AI answers, marked with a preferred badge. One tap, free, undo anytime.
Add us as a preferred sourceOpens Google's source preferences for theglp1daily.com. No sign-up with us — it's a Google setting.